Answers are grounded in this paper and cite their sources.
Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail. Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail. Immunoglobulin A (IgA) 1The abbreviations used are:IgAImmunoglobulin ASIgASecretory Immunoglobulin ApIgRpolymeric Immunoglobulin ReceptorHexhexoseHexNAcN-acetylhexosamineGlcNAcN-acetylglucosamineFucfucoseNeuAcN-acetylneuraminic acidPGCporous graphitized carbonECCextracted compound chromatogramEICextracted ion chromatogramsSCfree IgA Secretory Component. 1The abbreviations used are:IgAImmunoglobulin ASIgASecretory Immunoglobulin ApIgRpolymeric Immunoglobulin ReceptorHexhexoseHexNAcN-acetylhexosamineGlcNAcN-acetylglucosamineFucfucoseNeuAcN-acetylneuraminic acidPGCporous graphitized carbonECCextracted compound chromatogramEICextracted ion chromatogramsSCfree IgA Secretory Component. is a major component of the adaptive immune system, being the most abundant immunoglobulin expressed at mucosal surfaces and the second most abundant immunoglobulin in circulation (1Arnold J.N. Wormald M.R. Sim R.B. Rudd P.M. Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol. 2007; 25: 21-50Crossref PubMed Scopus (996) Google Scholar). Further, the human body expends a substantial amount of energy to synthesize serum and mucosal IgA daily, when compared with all the other immunoglobulins combined (66 mg per 1kg of body weight) (1Arnold J.N. Wormald M.R. Sim R.B. Rudd P.M. Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol. 2007; 25: 21-50Crossref PubMed Scopus (996) Google Scholar, 2Woof J.M. Ken M.A. The function of immunoglobulin A in immunity.J. Pathol. 2006; 208: 270-282Crossref PubMed Scopus (468) Google Scholar). In contrast to other immunoglobulins, IgA is characterized by a unique structural heterogeneity. Secretory IgA (SIgA) is present in mucosal secretions, including milk, saliva, tears, intestinal, and cervical fluids. SIgA and can be structurally classified as a homodimer, joined by a polypeptide (J chain); both components are produced by plasma cells in the lamina propria of mucosal surfaces. This dimeric IgA is then translocated across epithelial cells, and during this process, the secretory component (which derives from the polymeric immunoglobulin receptor, pIgR) completes SIgA complex formation via disulfide bonding. Two IgA subclasses or isotypes have been described in mucosal surfaces: whereas IgA1 carries an extra thirteen amino acids in the hinge region of the heavy chain molecule, IgA2 is genetically polymorphic and exists as three allotypes, designated IgA2m(1), IgA2m(2), and IgA2n (3Herr A.B. Ballister E.R. Bjorkman P.J. Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc.Nature. 2003; 423: 614-620Crossref PubMed Scopus (223) Google Scholar). Plasma IgA is predominantly monomeric and is produced by bone marrow plasma cells. Plasma IgA is composed of 90% of IgA1 and 10% of IgA2 (4Yoo E.M. Morrison S.L. IgA: An immune glycoprotein.Clin. Immunol. 2005; 116: 3-10Crossref PubMed Scopus (48) Google Scholar). In contrast to plasma IgA, which is mostly IgA1 subtype, SIgA presents both isotypes with up to 50% of IgA2 isotype (4Yoo E.M. Morrison S.L. IgA: An immune glycoprotein.Clin. Immunol. 2005; 116: 3-10Crossref PubMed Scopus (48) Google Scholar). Immunoglobulin A Secretory Immunoglobulin A polymeric Immunoglobulin Receptor hexose N-acetylhexosamine N-acetylglucosamine fucose N-acetylneuraminic acid porous graphitized carbon extracted compound chromatogram extracted ion chromatograms free IgA Secretory Component. Immunoglobulin A Secretory Immunoglobulin A polymeric Immunoglobulin Receptor hexose N-acetylhexosamine N-acetylglucosamine fucose N-acetylneuraminic acid porous graphitized carbon extracted compound chromatogram extracted ion chromatograms free IgA Secretory Component. N-Glycosylation is a common post-translational modification influencing protein structure and biological function, and therefore, implying major roles in human health that are only now addressable in structural detail (5Wu D. Struwe W.B. Harvey D.J. Ferguson M.A.J. Robinson C.V. N-glycan microheterogeneity regulates interactions of plasma proteins.Proc. Natl. Acad. Sci. 2018; 115: 8763-8768Crossref PubMed Scopus (70) Google Scholar, 6Ohtsubo K. Marth in mechanisms of health and 2006; PubMed Scopus Google Scholar). N-Glycans can be classified in high mannose, or N-Glycans. In an that a high mannose structures are produced in the and then can be to or complex glycans, which can be with fucose or acid IgA is a complex (4Yoo E.M. Morrison S.L. IgA: An immune glycoprotein.Clin. Immunol. 2005; 116: 3-10Crossref PubMed Scopus (48) Google Scholar). IgA1 and IgA2 N-glycosylation in the region of the heavy whereas all the other of IgA2 N-glycosylation and IgA2n one N-glycosylation (4Yoo E.M. Morrison S.L. IgA: An immune glycoprotein.Clin. Immunol. 2005; 116: 3-10Crossref PubMed Scopus (48) Google Scholar). of SIgA is as this one N-glycosylation on the chain and N-glycosylation on the secretory Interestingly, of N-Glycans from both SIgA and free secretory component the with the role of IgA glycosylation in of by and secretory immunoglobulin A is by PubMed Scopus Google and interactions were to to IgA of of K. IgA regulates the and function of by 2018; PubMed Scopus Google Scholar). Further, have that in human milk SIgA N-Glycans including mannose, and acid are potential and including and Harvey D.J. Wormald M.R. D. M.R. Dwek R.A. Rudd P.M. Secretory IgA and provide a the and adaptive immune 2003; PubMed Scopus Google Scholar, on secretory component in protection against mucosal 2006; PubMed Scopus Google Scholar, An in that in the human Natl. Acad. Sci. 2006; Scopus Google Scholar). this biological role of IgA glycosylation in and structural of SIgA of its and heterogeneity. in and essential K. Rudd P.M. A to protein glycosylation A the PubMed Scopus Google Scholar, to glycomic and Rev. 2018; PubMed Scopus Google Scholar). the most glycosylation of SIgA in human glycosylation of secretory immunoglobulin a from human PubMed Scopus Google Scholar). and characterized plasma IgA during plasma changes during PubMed Scopus Google Scholar, K. D. P.J. of immunoglobulin A glycosylation during by of PubMed Scopus Google Scholar). from salivary SIgA from and were of immunoglobulin A and from saliva and plasma Immunol. 2018; PubMed Scopus Google Scholar). of IgA glycosylation in of the same lactating been in glycosylation during have been described in plasma IgA plasma changes during PubMed Scopus Google Scholar, K. D. P.J. of immunoglobulin A glycosylation during by of PubMed Scopus Google and a human milk study that delivery mode the milk D. milk and glycosylation by delivery Sci. PubMed Scopus Google Scholar). that SIgA from breast milk a role in the passive immunity of the infant during and at the that the lactating from as as plasma IgA and salivary is a of the IgA in or different glycosylation lactating In this we characterized the mature breast milk and salivary SIgA N-glycan and compared to the N-glycan from plasma IgA purified from the same lactating participants. plasma IgA N-glycosylation of participants used as a to the of we evaluated the of SIgA and plasma IgA could be by delivery protein from and were from were from free and were from from and acid from graphitized carbon were from used the Plasma IgA from milk, saliva, and plasma were from a of in the study at the of the of PubMed Scopus Google Scholar). These were on from who by vaginal delivery or The of all lactating participants plasma were from and participants in a study and used as this The all of both and from all participants. The study on were by in the with a on the previously in human a and PubMed Scopus Google which milk from one breast a one breast into a into a and the in were up to the on and at were into a by participants. Lactating participants and of a of one saliva a were on and of the at at plasma were on during and at SIgA from milk and saliva and IgA from plasma were purified by as described milk and saliva and plasma glycosylation of secretory immunoglobulin a from human PubMed Scopus Google Scholar). milk and saliva were at at to the and and the to a new were with of and with in at were the and the three with IgA with and this by of were against and at of SIgA and IgA by by protein by of of purified SIgA from milk and saliva and plasma IgA were with in and with in in the N-Glycans were with and purified by graphitized carbon as previously described D. changes in glycosylation epithelial high mannose structures the of PubMed Scopus Google Scholar). were with acid and were the graphitized carbon and with N-Glycans were with in were at serum IgA N-Glycans were and as a the and N-Glycans from milk, saliva, and plasma of lactating participants with vaginal delivery and were were then with in a and graphitized carbon as described in the with or were performed in at were on a were in the same N-Glycans were in of and by a as previously described D. glycosylation is to changes in PubMed Scopus Google Scholar). were at per with a to of in ion were to an ion with N-Glycans were from N-glycan from milk, saliva, and plasma of all participants The and the used were to used in the performed in the ion mode the N-glycan and mode used with to and were as and and were on the and were selected as and were given second and whereas all the other were given with on the of the to the is and is The of and and and were used to fucosylated, and sialylated species, with to a whereas all other to or to A in of Scopus Google Scholar). were previously of in of and with the PubMed Scopus Google Scholar). N-Glycans were identified and in with an N-glycan of all glycan compositions to An The of glycan to and the human serum PubMed Scopus Google including and high mannose glycan with ion of were and a used to the to the of previously and of glycan An glycan with and the of PubMed Scopus Google Scholar, K. of PubMed Scopus Google Scholar). of glycan compositions by all of a glycan and to the of all the glycans present in the The milk and saliva SIgA, and plasma IgA characterized in and as glycan with from all and have been at the with an were performed and the of glycan of used to compare glycans as the the three as the breast milk, and used the and were performed to compare glycan from plasma IgA of lactating and delivery and participants. A used to compare glycans vaginal and delivery the had an of the N-glycan of SIgA from mature breast milk and saliva and IgA from plasma as of IgA from all three body unique glycan that may correspond to over 250 structures combined were into different high mannose, sialylated and and undecorated fucosylated on and the or of fucose and acids as glycans and that are are may glycan structures of different The of structures were by the of by the of glycans with and were by the of glycans with one to fucose on the of acids glycan compositions were identified in SIgA from mature breast milk, in the The are with unique in the are the structures have been milk, the most abundant were and glycans whereas undecorated and glycans were the abundant mannose glycans were the abundant The most abundant in milk SIgA are in the or glycan in and with structures. A of and high mannose glycans were a common whereas of glycans and of glycans were Interestingly, the of sialylated glycans were In mature breast milk SIgA, only of the glycans and a high of of of N-Glycans in IgA from lactating are as and are as and are as and highly and highly and highly and are as and highly in a new In salivary SIgA, over different glycan compositions were identified and in milk SIgA, salivary SIgA presented glycans as the most abundant undecorated glycans increased whereas structures to an that high mannose glycans Interestingly, sialylated were the abundant with mature milk, SIgA structures were in saliva, with a of and high mannose glycans and glycans were the most abundant fucosylated with and glycans in than in mature milk SIgA, most of the were In glycans were and than in mature breast milk In contrast to the described mature breast milk and salivary SIgA, the plasma IgA presented a diversity of glycan species, with over different glycan compositions and and Plasma IgA a high of glycans by glycans and high mannose glycans were the abundant in plasma IgA. in SIgA from mature milk and saliva, the of the abundant glycans in plasma IgA were with a of and high mannose glycans and a common and in contrast to in SIgA, glycans were abundant in plasma IgA compared with SIgA from milk and saliva, all fucosylated glycans were Interestingly, in plasma IgA, glycans were than mature milk SIgA, and than salivary IgA. A N-glycan of SIgA from milk and saliva, and plasma IgA to over glycan compositions that on in a body-fluid In mature milk SIgA, N-Glycans were to be abundant than in salivary SIgA and plasma IgA and to and N-Glycans. Among glycans with one or fucose to the most abundant glycans in milk salivary SIgA, glycans were abundant and to and glycans with glycans were present in salivary Further, in plasma IgA, we identified abundant and were the and glycan of these were the most abundant glycans abundant N-Glycans in mature breast milk are as are as are as highly and highly and is as and the of are as highly in a new abundant N-Glycans in salivary are as are as are as highly and highly and is as and the of are as highly in a new abundant N-Glycans in plasma are as are as are as highly Plasma and highly Plasma and is as and the of are as highly in a new is as and the of is as and the of is as and the of Interestingly, we glycans to be abundant in SIgA from mature milk and saliva than in plasma IgA. The of these glycans were by and undecorated glycans to and were the most abundant in mature milk and saliva abundant N-Glycans in SIgA are as are as are as highly and highly and in the and the chain by N-glycan in the and the chain by in the and the chain by in the and the chain by in the and the chain by in the and the chain by N-glycan in the and the chain by in the and the chain by N-glycan in the and the chain by in the and the chain by N-glycan in the and the chain by in the and the chain by N-glycan in the and the chain by N-glycan in the and the chain by in the and the chain by N-glycan in the and the chain by in the and the chain by in the and the chain by in the and the chain by in the and the chain by in the and the chain by in the and the chain by N-glycan is as and the of are as highly in the and the chain by N-glycan in the and the chain by in the and the chain by in a new is as and the of the delivery mode (S)IgA milk, and saliva SIgA and plasma IgA, the N-glycosylation from body from lactating participants who were compared with from participants who by In salivary SIgA, lactating participants who by of and and fucosylated glycans with one and up to fucose and and of glycans were only to salivary SIgA, as plasma IgA from lactating participants who by in and and glycans compositions and were in participants with A the abundant glycans and glycans and glycans of delivery mode were in milk SIgA N-Glycans. sialylated glycans from plasma IgA by delivery we evaluated the of acid different sialylated glycans with and we that the of and is by delivery mode in plasma IgA we compared the N-glycosylation of plasma IgA from lactating participants with participants. we high mannose glycans with of these structures in plasma IgA from lactating participants who had a vaginal both when compared with participants and lactating participants who had by IgA is the most abundant immunoglobulin expressed at mucosal surfaces and the second most abundant immunoglobulin in playing a central role in both the and immune This study and the the N-glycosylation of mature breast milk and saliva secretory IgA (SIgA) and plasma IgA from the same lactating a The effect of delivery mode on IgA glycosylation evaluated by (S)IgA N-glycosylation of that or by with as The of over glycan compositions is in SIgA purified from mature breast milk and saliva, A glycans from plasma IgA. Interestingly, 50% of all these glycans compositions have been described in milk, saliva and plasma which may be of the of the over glycomic K. S.L. of glycomic as a epithelial PubMed Scopus Google Scholar, S.L. K. K. N-glycosylation in PubMed Scopus Google Scholar). The N-glycosylation mature breast milk SIgA at of and and of as compared with previously SIgA N-Glycans (1Arnold J.N. Wormald M.R. Sim R.B. Rudd P.M. Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol. 2007; 25: 21-50Crossref PubMed Scopus (996) Google Scholar, Harvey D.J. Wormald M.R. D. M.R. Dwek R.A. Rudd P.M. Secretory IgA and provide a the and adaptive immune 2003; PubMed Scopus Google Scholar). new glycans compositions are with mainly fucosylated up to fucose and with or acids This in N-glycan diversity in mature breast milk SIgA, and specifically on fucosylated species, with in human milk we have an in during the from to mature breast milk of human milk changes during lactation its role in PubMed Scopus Google Scholar). This in could be a common in the of the human milk during and from The changes a in mature breast to and on the This is by the increased of fucosylated and sialylated structures on mature breast milk SIgA including and which have been to as and (1Arnold J.N. Wormald M.R. Sim R.B. Rudd P.M. Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol. 2007; 25: 21-50Crossref PubMed Scopus (996) Google as of of to by immunoglobulin and of human and breast PubMed Scopus Google a role in interactions and PubMed Scopus Google An in that in the human Natl. Acad. Sci. 2006; Scopus Google and milk that of to human in PubMed Scopus Google Scholar). Further, this glycosylation in the of the that N-Glycans present on the of SIgA interactions with of by and secretory immunoglobulin A is by PubMed Scopus Google Scholar, K. IgA regulates the and function of by 2018; PubMed Scopus Google Scholar, on secretory of the secretory IgA and PubMed Scopus Google Scholar). that human to to SIgA to epithelial cells and mucosal The that with of the against K. IgA regulates the and function of by 2018; PubMed Scopus Google Scholar, on secretory of the secretory IgA and PubMed Scopus Google Scholar, Bjorkman P.J. immunoglobulin A mucosal 2018; PubMed Scopus Google Scholar). In this the role of milk SIgA N-Glycans in the of the and mainly The of mature breast milk SIgA N-Glycans presented in this a the SIgA glycan that and In this we the most of salivary SIgA and the study from lactating a highly of over glycan only one in the of salivary SIgA N-Glycans from and of immunoglobulin A and from saliva and plasma Immunol. 2018; PubMed Scopus Google Scholar). with and we of and which is of as previously identified in plasma IgA D. A.B. P.J. by high glycosylation of human plasma and immunoglobulin Scopus Google Scholar). may these in glycosylation as we the of modification in the from salivary SIgA, and modification as the of and acid per glycan identified in a of immunoglobulin A and from saliva and plasma Immunol. 2018; PubMed Scopus Google Scholar). we have described a of glycans of a in the of of and of In this the of the mucosal SIgA mature breast milk and saliva from the same participants and Interestingly, the most abundant glycans compositions were common to both and in a that milk and salivary SIgA could from mucosal and as a of SIgA and been that of IgA heavy chain the protein in and with IgA of glycosylation immunoglobulin A and Scopus Google Scholar, J.M. of the human IgA1 heavy chain that Immunol. PubMed Google Scholar). in glycosylation were salivary SIgA of and of glycans than mature breast milk SIgA This of sialylated glycans, including and species, in with of undecorated glycans in salivary SIgA glycans, may from the with from as and which have been described as acid at the saliva Immunol. 2018; PubMed Scopus Google Scholar, acids are an optimal in Scopus Google Scholar, of to salivary PubMed Google Scholar). fucosylated glycans are the of the The of protein from specifically PubMed Scopus Google Scholar). we identified body-fluid glycans milk and saliva being glycans than in milk and could that salivary and mature milk SIgA only from a mucosal N-glycosylation from an the of glycans that will protect the from mucosal and the from of glycans need to be in SIgA from both mature breast milk and saliva, and is This study characterized the most plasma IgA N-Glycosylation of plasma IgA than other body given its potential role a of human including and IgA including a in been identified as a potential IgA IgA glycosylation and IgA immune in the of IgA PubMed Scopus Google Scholar, The role of IgA1 in the of IgA 2007; PubMed Scopus Google and IgA N-glycosylation been in D. A.B. P.J. by high glycosylation of human plasma and immunoglobulin Scopus Google and K. S.L. glycosylation of immunoglobulins in serum of PubMed Scopus Google Scholar, M.R. of PubMed Scopus Google Scholar). have been on plasma IgA N-glycosylation in as and lactation plasma changes during PubMed Scopus Google Scholar, K. D. P.J. of immunoglobulin A glycosylation during by of PubMed Scopus Google Scholar). In with these the most abundant in plasma IgA from lactating to and glycans with and and the and glycans with and and to glycans were the most Interestingly, we the of glycans previously to be increased during and up to in heavy chain K. D. P.J. of immunoglobulin A glycosylation during by of PubMed Scopus Google Scholar). of plasma IgA glycans with SIgA glycans from mature breast milk and saliva the of glycan compositions and glycan compositions and sialylated glycans in plasma IgA were abundant that in mature breast milk and saliva, and glycans were only in plasma IgA. A the fucosylated This of sialylated in plasma IgA may only the glycosylation of bone marrow the of mechanisms at highly sialylated acid a role in the of is that in the IgA be produced and in a highly sialylated IgA are from circulation by the in the (1Arnold J.N. Wormald M.R. Sim R.B. Rudd P.M. Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol. 2007; 25: 21-50Crossref PubMed Scopus (996) Google the of sialylated the of of a by the and the of and into the circulation of Natl. Acad. Sci. PubMed Scopus Google a plasma IgA be the mucosal glycans identified in SIgA, of were in the secretory component and chain glycosylation of secretory immunoglobulin a from human PubMed Scopus Google Scholar, of immunoglobulin A and from saliva and plasma Immunol. 2018; PubMed Scopus Google Scholar). This that glycosylation IgA and mucosal dimeric SIgA, and the diversity of glycans in plasma IgA, may from the of monomeric IgA and the of secretory component and chain in plasma IgA. This an to the mainly in contrast to the mucosal and that complex of and and that delivery mode on plasma IgA and salivary SIgA in a body-fluid a potential role of hormonal of IgA glycosylation. The hormonal and is the of the of and In vaginal delivery results from a complex and of that a of of and and of and K. of PubMed Google Scholar). a of and in maternal at the of may during delivery by is that may be in who a by Interestingly, have been to and of and of PubMed Scopus Google Scholar). results of of sialylated glycans in plasma IgA in that by may from a of at at the of is to the impact and biological of in IgA glycosylation and maternal In this study characterized and compared the the secretory IgA of mature breast milk and saliva with plasma IgA of the same lactating who or by The by revealed a greater diversity of glycans than and over body-fluid N-glycan of which are by delivery This study could be to the maternal of (S)IgA glycosylation and the role of mature milk SIgA N-Glycans that the of the and the design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail. that the study may salivary the of as and as and or and have been at the with an with
No takes yet. Share an insight, caveat, or question.
Goonatilleke et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: